Last update 01 Nov 2024

GC SHOWAYAKUHIN CORPORATION

1948|
Tokyo-to, Japan
|
www.gc-showayakuhin.com

Overview

Tags

Mouth and Tooth Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
ADRA1 x SCNA x β-adrenoceptors1

Related

2
Drugs associated with GC SHOWAYAKUHIN CORPORATION
Zinc oxide/Clove oil
Target-
Mechanism-
Active Org.
GC SHOWAYAKUHIN CORPORATION
Originator Org.
GC SHOWAYAKUHIN CORPORATION
Active Indication
Periodontal Diseases
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date22 Feb 1988
Articaine Hydrochloride/Epinephrine Bitartrate
Target
ADRA1 x SCNA x β-adrenoceptors
Mechanism
ADRA1 agonists [+2]
Active Org.
Deproco, Inc. [+4]
Originator Org.
Septodont
Active Indication
Anesthesia
Inactive Indication
Inflammatory pain
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
DE
First Approval Date01 Jan 1976
100 Clinical Results associated with GC SHOWAYAKUHIN CORPORATION
Login to view more data
0 Patents (Medical) associated with GC SHOWAYAKUHIN CORPORATION
Login to view more data
100 Deals associated with GC SHOWAYAKUHIN CORPORATION
Login to view more data
100 Translational Medicine associated with GC SHOWAYAKUHIN CORPORATION
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Zinc oxide/Clove oil
Periodontal Diseases
More
Approved
Articaine Hydrochloride/Epinephrine Bitartrate
 ( ADRA1 x SCNA x β-adrenoceptors )		Anesthesia
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free